SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-17-001187
Filing Date
2017-02-14
Accepted
2017-02-14 12:01:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 LOMBARD ODIER ASSET MANAGEMENT (USA) CORP p17-0369sc13ga.htm SC 13G/A 54327
  Complete submission text file 0000902664-17-001187.txt   55918
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Subject) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87931 | Film No.: 17605387
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 452 FIFTH AVENUE, 25TH FLOOR NEW YORK NY 10018
Business Address 452 FIFTH AVENUE, 25TH FLOOR NEW YORK NY 10018 212-295-6200
Lombard Odier Asset Management (USA) Corp (Filed by) CIK: 0001491719 (see all company filings)

IRS No.: 061603711 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A